ResearchMoz

Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-12-04
No. Of Pages » 80
 Cardiac prosthetic devices increase the survival rate and improve the quality of life in most patients. These devices are used to replace damaged or diseased natural valves of the heart. The research report on cardiac prosthetic devices provides a detailed analysis of the global market and helps in understanding the driving forces for growth of these devices. The report also provides analysis of major segments such as heart valves (mechanical heart valves, tissue heart valves and transcatheter heart valves) and pacemakers (implantable pacemaker and external pacemaker). Market size estimates and forecasts for the period 2011 to 2019 have been given for each segment and its sub-segments, in terms of USD million, using 2012 as the base year for calculations. 
   
 The market has been...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising Geriatric Population
3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints
3.3.1 Implementation of Affordable Healthcare Act
3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)

Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
4.2 Heart Valves
4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.2 Mechanical Heart Valves
4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
4.2.3 Tissue Heart Valves
4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.3.2 Stented Tissue Valve
4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.3.1 Stentless Tissue Valve
4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.4 Transcatheter Heart Valves
4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.2 Implantable Pacemaker
4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.3.1 Single-Chamber Battery Pacemaker
4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.3.2 Dual-Chamber Battery Pacemaker
4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.3.3 Triple-Chamber Battery Pacemaker
4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
4.3.4 External Pacemaker
4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)

Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview
5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
5.3 North America
5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.4 Europe
5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.5 Asia-Pacific
5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.6 Rest of the World (RoW)
5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Abiomed, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 AtriCure, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
7.5.1 Company overview
7.5.2 Financial overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Medtronic, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Siemens Healthcare
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Sorin Group
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Cardiac Prosthetic Devices Market (2012 & 2019)
TABLE 2 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
TABLE 3 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 4 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 7 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 8 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 11 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Cardiac Prosthetic Devices: Market Segmentation
FIG. 2 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
FIG. 3 Porter’s Five Forces Analysis: Cardiac Prosthetic Devices Market
FIG. 4 Market Attractiveness Analysis: Global Cardiac Prosthetic Devices Market, by Geography
FIG. 5 Cardiac Prosthetic Devices: Market Share, by Key Players, 2012 (%)
FIG. 6 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
FIG. 7 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 8 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 9 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
FIG. 10 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 11 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 12 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 13 Global External Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 14 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 15 Abbott Laboratories, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 16 Abiomed, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 17 AtriCure, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 18 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Edward Lifesciences Corporation, Net Sales: 2010 – 2012 (USD Billion)
FIG. 20 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Sorin Group, Net Sales: 2010 – 2012 (USD Million)
FIG. 23 St. Jude Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

Upcoming Reports:

Poland: malt market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the malt market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the malt market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Fluid Catalytic Cracking Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
A Fluid catalytic cracking (FCC) unit is an integral part of an oil refinery. It was first introduced in the U.S by Exxon Corporation on account of the growing need for hydrocarbon based fuels.  It is mostly used to convert high molecular weight and high boiling point hydrocarbons to more valuable products such as olefinic gases, gasoline and other petroleum products. Thermal catalytic process has been completely replaced by fluid catalytic cracking unit as it produces more quantity of gasoline with high octane rating. FCC units are segmented based on their configuration such...
Immunocytokines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Immunocytokines are defined as the category of molecules made by linking tumor-reactive monoclonal antibodies with cytokines leading to activation of immune cells. This molecule is majorly used to treat tumors as tumor selective localization is possible due to ability of molecular antibodies element to bind with molecules on tumor cell surface or molecule activating immune cells with appropriate receptors. The market for the immunocytokines is majorly classified into three segments, on the basis of disease condition, targeting sites and clinical trials. Based on disease conditions, the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Demand for Big-Screen iPhones Observed More by 4 Million than for Earlier Versions
Sep 16, 2014  
Apple Inc. has observed pre-orders more than 4 million for its new version of iPhone as compared to what was observed for previous versions of iPhones, in the first 24 hours of launch. The demand for the smartphones already seems to outstrip supply, expected to start by the end of this week.   iPhone 6 and iPhone 6 Plus, company’s recent smartphone launches with bigger...
LiquidM Launches New Mobile with Improved Retargeting Facilities
Sep 15, 2014  
Mobile Advertising Management Platform (MAMP) the only white-labeled LiquidM introduced retargeting capabilities in its newly launched mobile today. These capabilities help the mobile advertisers and developers reestablish contacts with their customers. It helps remind people to revisit the website, complete the purchase or remind people who have already visited the website for digital...
Open to Hiring Malaysia Airlines Retrenched Employees : AirAsia CEO
Sep 11, 2014  
After reports that Malaysia Airlines will be letting go nearly 6,000 of its staff, chief executive officer of low-cost carrier AirAsia Tan Sri Tony Fernandes has said that he is open to hiring MAS ex-employees as part of its own workforce.  Fernandes said that he welcomes the MAS overhaul and the transition will be a good move for the AirAsia group as well as Malaysia Airlines....
Statoil Expands Natural Gas in Bakken
Sep 11, 2014  
A Norway-based oil company, Statoil known for dealing in natural gas has stamped its strong presence in Bakken, North Dakota. In the last three years, emissions from burning, flaring of methane, natural gas, and hydrogen sulphide related with oil production have risen tremendously. Statoil operates in the effort to expand the technology to power equipment with natural gas that would otherwise...
Apple Watch - The Latest Product Launched By Apple Inc
Sep 11, 2014  
The sale of large screen phones may witness a boost due to the additional feature of mobile payment service that has been included in Apple Inc’s latest iPhone. This could restore the market share of Apple Inc that was lost to Google Inc’s Android segment. Soon after the launch of the Apple Watch and iPhone 6, the shares of Apple rose by almost 1.3% on Wednesday. This also...